EC Advertising in Bulgaria
As evidenced by these pictures from Bulgaria, some European countries allow advertising of over-the-counter medical products. This particular ad is for EC and has been placed on the side of a shopping cart.
February 2022. The Council of Europe Commissioner for Human Rights strongly urges Maltese authorities to improve the availability of sexual and reproductive health services. In her report, published on February 15, Commissioner Dunja Mijatović notes that numerous pharmacies refuse to dispense EC on grounds of conscience, and that there are no measures in place to…
August 2022. The Asia Pacific and the European EC consortia (APCEC and ECEC) are organizing a casual gathering within FIAPAC’s upcoming conference, to talk about emergency contraception (EC). Please join us for lunch at the 14th FIAPAC Conference in Riga, on September 10th for a conversation on how to scale up access to emergency contraception…
May 2021. Findings from ECEC’s and You Act’s participatory survey on emergency contraception access through community pharmacies in Europe, were presented on a poster at the European Society of Contraception and Reproductive Health (ESCRH) virtual seminar held on May 7 and 8, 2021. We thank the ESCRH colleagues for this opportunity to share our work.

May 2025. Sales of emergency contraception (EC) pills are rising again in Norway after a few years of gradual decline, according to the latest drug consumption report from the Norwegian Institute of Public Health (Folkehelseinstituttet), published in June 2024. In 2023, approximately 129.000 packages of EC pills were sold nationwide. This marks a reversal of…
The Spanish Society of Contraception (SEC) just launched the Spanish edition of emergency contrantraception: A guideline for service provision in Europe, published by ECEC in December 2013. Anticoncepción de Urgencia. Guía para la provisión de servicios en Europa, can be downloaded from the SEC´s website, here. ECEC thanks the SEC for this collaboration and for their efforts…

January 2025. The findings of a proof-of-concept study investigating use of ulipristal acetate (UPA) as part of an abortion regimen, have been published this week. UPA is the active ingredient in the newer generation of emergency contraception (EC) pills. The publication of this research may open a global debate about the development of new indications…
Menú